JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C8661 4-Methoxychalcone-1

Summary: A PPARγ agonist

≥39.4 mg/mL
A8194 ABT-199
30 Citation

Target: Bcl-2

Summary: Bcl-2 inhibitor,potent and selective

≥43.42 mg/mL
A4092 CUDC-101
1 Citation

Target: Histone Deacetylases (HDACs)|EGFR|ErbB

Summary: Multitargeted HDAC inhibitor

≥21.7 mg/mL
A4143 CYT387
1 Citation

Summary: JAK-1/-2 inhibitor,ATP competitive

insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
A4101 Tubastatin A
11 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
A4125 CYC116

Target: Aurora Kinases|FLT3|VEGFR

Summary: Potent Aurora A/B inhibitor

insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
A4343 Dyphylline

Summary: Pan-PDE inhibitor

≥17.17 mg/mL
A8163 AM 114
2 Citation

Target: Proteasome

Summary: 20S proteasome inhibitor

insoluble in H2O; ≥16.65 mg/mL
A8165 Q-VD(OMe)-OPh
6 Citation

Target: Caspases

Summary: Pan-caspase inhibitor

≥26.35 mg/mL
A3236 Benfotiamine

Summary: Drug for painful nerve condition

insoluble in H2O; insoluble in EtOH; insoluble in DMSO